A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

IsraelRecruitingPHASE1, PHASE2

Conditions

Metastatic Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • City of Hope, Duarte, California, United States

  • University of California San Diego Medical Center, La Jolla, California, United States

  • Stanford Cancer Institute, Stanford, California, United States

  • Rocky Mountain Cancer Center - Longmont, Longmont, Colorado, United States

  • H. Lee Moffitt Cancer Center and Research Inst., Tampa, Florida, United States

  • Hackensack Univ Medical Center, Hackensack, New Jersey, United States

  • Regional Cancer Care Associates, LLC, Howell Township, New Jersey, United States

  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

  • NYU Langone Medical Center, New York, New York, United States

  • Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

  • University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

  • Tennessee Oncology - Chattanooga Oncology & Hematology Associates, Chattanooga, Tennessee, United States

  • The West Clinic, Germantown, Tennessee, United States

  • Tennessee Oncology PLLC, Nashville, Tennessee, United States

  • Vanderbilt University Medical Center, Nashville, Tennessee, United States

  • Texas Oncology-Plano East, Plano, Texas, United States

  • Peter MacCallum Cancer Centre-East Melbourne, Melbourne, Victoria, Australia

  • Fiona Stanley Hospital - Medical Oncology, Murdoch, Western Australia, Australia

  • Centre Léon Bérard, Lyon, France

  • Institut régional du Cancer Montpellier, Montpellier, France

  • Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France

  • Gustave Roussy, Villejuif, France

  • Universitätsklinikum Erlangen, Erlangen, Germany

  • Universitätsklinikum Essen, Essen, Germany

  • Rambam Medical Center, Haifa, Israel

  • Shaare Zedek Medical Center, Jerusalem, Israel

  • Hadassah University Medical Center, Jerusalem, Israel

  • Rabin MC, Petah Tikva, Israel

  • Sheba Medical Center, Ramat Gan, Israel

  • Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel

  • Assuta Medical Centers, Tel Aviv, Israel

  • National Cancer Center Clinical Trials Center / Center for Breast Cancer, Goyang-si, South Korea

  • Seoul National University Hospital, Seoul, South Korea

  • Severance Hospital, Seoul, South Korea

  • University of Ulsan College of Medicine - Asan Medical Center, Seoul, South Korea

  • Samsung Medical Center, Seoul, South Korea

  • Hospital Universitario Virgen Macarena, Seville, Sevilla, Spain

  • Hospital del Mar, Barcelona, Spain

  • Vall d?Hebron Institute of Oncology (VHIO), Barcelona, Barcelona, Spain

  • Hospital Universitario Ramon y Cajal, Madrid, Spain

  • Centro Integral Oncológico Clara Campal Ensayos Clínicos START, Madrid, Spain

  • National Cheng Kung University Hospital, Tainan, Taiwan

  • National Taiwan University Hospital, Taipei, Taiwan

  • Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

  • Barts Health NHS Trust - St Bartholomew's Hospital, London, United Kingdom

Study leads
  • Clinical Trials

    Study Director

    Hoffmann-La Roche